早期宫颈神经内分泌癌根治性子宫切除术后放疗作用的Meta分析
该Meta分析纳入13项研究,评估早期宫颈神经内分泌癌根治性子宫切除术后辅助放疗与未放疗患者的复发和死亡。放疗组总体复发63/120(52.5%) vs 未放疗组70/185(37.8%)(RR 1.21,95%CI 0.85-1.70,P=0.29);盆腔复发15/120(12.5%) vs 45/185(24.3%)(RR 0.60,95%CI 0.34-1.08,P=0.09);死亡138/396(34.8%) vs 223/632(35.2%)(RR 1.08,95%CI 0.75-1.56,P=0.66)。作者认为术后常规放疗可能减少盆腔复发,但似乎不降低总体复发或死亡。
要点
- 早期NECC根治术后放疗组总体复发RR 1.21(95%CI 0.85-1.70),未达统计学显著。
- 放疗组盆腔复发RR 0.60(95%CI 0.34-1.08),未达统计学显著。
- 放疗组死亡RR 1.08(95%CI 0.75-1.56),未达统计学显著。
核心结论
- 对所有早期NECC根治性子宫切除术后患者常规加用术后放疗可能减少盆腔复发,但似乎不降低总体复发或死亡。
- 作者认为,对于合并其他高危病理因素的患者,术后放疗可能仍有作用。
研究设计与样本
- 对13项独特研究行Meta分析,纳入报告早期NECC根治性子宫切除术后是否接受辅助放疗患者复发和/或死亡的研究。
主要发现
- 5项研究报告总体复发率:放疗组63/120(52.5%) vs 未放疗组70/185(37.8%)(RR 1.21,95%CI 0.85-1.70,P=0.29)。
- 5项研究报告盆腔复发率:放疗组15/120(12.5%) vs 未放疗组45/185(24.3%)(RR 0.60,95%CI 0.34-1.08,P=0.09)。
- 13项研究报告死亡率:放疗组138/396(34.8%) vs 未放疗组223/632(35.2%)(RR 1.08,95%CI 0.75-1.56,P=0.66)。
临床怎么用
- 原文结论未据此给出常规术后放疗的推荐。
- 作者认为合并其他高危病理因素的患者术后放疗可能仍有作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Neuroendocrine carcinoma of the cervix (NECC) is an aggressive disease with high rates of nodal disease spread even in seemingly cervix-confined disease. Many providers routinely prescribe postoperative radiation therapy in an effort to reduce recurrences despite a lack of supporting studies. The objective of this study was to determine recurrence and mortality in patients with early-stage NECC who had pelvic radiation after radical hysterectomy compared to those who did not receive radiation. METHODS: We performed a meta-analysis of 13 unique studies that reported recurrence and/or mortality for patients with early-stage NECC who underwent radical hysterectomy with or without adjuvant radiation therapy. RESULTS: In 5 studies that reported overall recurrence rates, 63 (52.5%) of 120 patients who received postoperative radiation recurred compared to 70 (37.8%) of 185 patients who did not (RR 1.21, 95% CI: 0.85-1.70, p = 0.29). In 5 studies that reported pelvic recurrence rates, there were 15 pelvic recurrences (12.5%) in the 120 patients who received postoperative radiation compared to 45 pelvic recurrences (24.3%) in the 185 patients who did not (RR 0.60, 95% CI: 0.34-1.08, p = 0.09). In 13 studies that reported mortality rate, there were 138 deaths (34.8%) in 396 patients who received postoperative radiation therapy compared to 223 (35.2%) in 632 patients who did not (RR 1.08, 95% CI: 0.75-1.56, p = 0.66). CONCLUSIONS: The addition of routine postoperative radiation therapy in all patients with early-stage NECC after radical hysterectomy may reduce pelvic recurrences but does not appear to decrease overall recurrence or death. However, there may still be a role for postoperative radiation therapy in patients with additional high-risk pathologic factors.
引用
- Kim C, Salvo G, Ishikawa M, et al. The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: A meta-analysis. Gynecol Oncol. 2023. PMID: 36773379. doi:10.1016/j.ygyno.2023.01.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。